Aleix Prat/clinicbarcelona.org
Dec 30, 2024, 10:05
Translational genomics and targeted therapies in solid tumours – August Pi i Sunyer Biomedical Research Institute
August Pi i Sunyer Biomedical Research Institute – IDIBAPS shared a post on LinkedIn:
“The Translational genomics and targeted therapies in solid tumours group led by Aleix Prat uses genomic and molecular data to guide the design of clinical trials and the development of biomarkers to identify better treatments for patients.”
Aleix Prat is the Director of the Cancer Institute at the Hospital Clinic of Barcelona, Head of the Translational Genomics Group at IDIBAPS, and a Professor at the University of Barcelona.
He is also a Co-Founder of REVEAL GENOMICS, S.L. His work focuses on breast cancer genomics and the development of omics-based assays for clinical application. His expertise lies in breast cancer and gene expression profiling.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 10, 2025, 23:57